1. Home
  2. INTT vs HOWL Comparison

INTT vs HOWL Comparison

Compare INTT & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$19.20

Market Cap

234.0M

Sector

Technology

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.55

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
HOWL
Founded
1981
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.0M
30.7M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
INTT
HOWL
Price
$19.20
$0.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$13.50
$5.00
AVG Volume (30 Days)
453.8K
482.0K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
0.06
N/A
Revenue
$66,801,000.00
N/A
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
N/A
P/E Ratio
$314.17
N/A
Revenue Growth
66.06
N/A
52 Week Low
$5.64
$0.50
52 Week High
$20.00
$2.23

Technical Indicators

Market Signals
Indicator
INTT
HOWL
Relative Strength Index (RSI) 59.95 32.14
Support Level $7.37 N/A
Resistance Level $20.00 $0.74
Average True Range (ATR) 1.71 0.08
MACD -0.03 -0.02
Stochastic Oscillator 76.43 13.45

Price Performance

Historical Comparison
INTT
HOWL

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: